Literature DB >> 7937331

Bioactive peptides in anterior pituitary cells.

H Houben1, C Denef.   

Abstract

The anterior pituitary (AP) has been shown to contain a wide variety of bioactive peptides: brain-gut peptides, growth factors, hypothalamic releasing factors, posterior lobe peptides, opioids, and various other peptides. The localization of most of these peptides was first established by immunocytochemical methods and some of the peptides were localized in identified cell types. Although intracellular localization of a peptide may be the consequence of internalization from the plasma compartment, there is evidence for local synthesis of most of these peptides in the AP based on the identification of their messenger-RNA (mRNA). In several cases the release of the peptide from the AP cell has been shown and regulation of synthesis, storage and release have also been described. Because the amount of most of the AP peptides is very low (except for POMC peptides and galanin), endocrine functions are not expected. There is more evidence for paracrine, autocrine, or intracrine roles in growth, differentiation, and regeneration, or in the control of hormone release. To demonstrate such functions, in vitro AP experiments have been designed to avoid the interference of hypothalamic or peripheral hormones. The strategy is first to show a direct effect of the peptide after adding it to the in vitro system and, secondly, to explore if the endogenous AP peptide has a similar action by using blockers of peptide receptors or antisera immunoneutralizing the peptide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937331     DOI: 10.1016/0196-9781(94)90218-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

2.  GENE THERAPY FOR THE TREATMENT OF PITUITARY TUMORS.

Authors:  Silvia S Rodriguez; Maria G Castro; Oscar A Brown; Rodolfo G Goya; Gloria M Console
Journal:  Expert Rev Endocrinol Metab       Date:  2009-07-01

3.  Effect of concomitant progesterone administration or the effect of removal of estrogen capsule on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities.

Authors:  Andrea Heinzlmann; Katalin Köves; György M Nagy
Journal:  Endocrine       Date:  2010-03-30       Impact factor: 3.633

4.  Morphological changes induced by insulin-like growth factor-I gene therapy in pituitary cell populations in experimental prolactinomas.

Authors:  Gisela A Camihort; Claudia B Hereñú; Georgina C Luna; Silvia S Rodríguez; María I Bracamonte; Rodolfo G Goya; Gloria M Cónsole
Journal:  Cells Tissues Organs       Date:  2009-11-14       Impact factor: 2.481

5.  Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism.

Authors:  M G Welch; J D Keune; T B Welch-Horan; N Anwar; M Anwar; R J Ludwig; D A Ruggiero
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

6.  Corticotropin-releasing hormone is produced by rat corticotropes and modulates ACTH secretion in a paracrine/autocrine fashion.

Authors:  F Pecori Giraldi; F Cavagnini
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  Analysis of mitogenic activity of proteins after separation by gel electrophoresis.

Authors:  O Hohenwarter; G Marzban; E Jisa; K Vorauer-Uhl; H Katinger
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

8.  Sexual dimorphism in the effect of concomitant progesterone administration on changes caused by long-term estrogen treatment in pituitary hormone immunoreactivities of rats.

Authors:  Andrea Heinzlmann; Katalin Koves; Magdolna Kovacs; Valer Csernus
Journal:  Med Sci Monit       Date:  2011-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.